Summit Securities Group’s ANI Pharmaceuticals ANIP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,531	Closed	-$140K	–	311
2023 Q4	$140K	Buy	+2,531	New	+$140K	0.01%	141
2013 Q3	–	Sell	-2	Closed	–	–	309
2013 Q2	$0	Buy	+2	New	–	﹤0.01%	388